Back to search

Article

Investigating the mechanisms underlying Bortezomib resistance

2023-07-31

Abstract excerpt

Proteasome inhibitors such as Bortezomib, represent an established type of targeted treatment for several types of hematological malignancies, including multiple myeloma, Waldenstrom’s macroglobulinemia and mantle cell lymphoma, based on the cancer cell’s susceptibility upon impairment of the proteasome-ubiquitin system. However, a major problem limiting their efficacy is the emergence of resistance. Their applica...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b6ea6c16-a700-5c30-8c0f-2d4f1d066840
DOI
10.1101/2023.07.29.551081
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Investigating the mechanisms underlying Bortezomib resistanceDOI 10.1101/2023.07.29.551081
Select a neighboring publication to make it the new centre.